Logo image of 1BAYN.MI

BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis

Europe - BIT:1BAYN - DE000BAY0017 - Common Stock

27.3 EUR
+0.15 (+0.55%)
Last: 9/17/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, 1BAYN scores 3 out of 10 in our fundamental rating. 1BAYN was compared to 49 industry peers in the Pharmaceuticals industry. 1BAYN may be in some trouble as it scores bad on both profitability and health. 1BAYN has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year 1BAYN was profitable.
In the past year 1BAYN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: 1BAYN reported negative net income in multiple years.
1BAYN had a positive operating cash flow in each of the past 5 years.
1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

With a Return On Assets value of -3.25%, 1BAYN is not doing good in the industry: 67.35% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -11.25%, 1BAYN is doing worse than 67.35% of the companies in the same industry.
Industry RankSector Rank
ROA -3.25%
ROE -11.25%
ROIC N/A
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1BAYN.MI Yearly ROA, ROE, ROIC1BAYN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

1BAYN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 54.95%, 1BAYN is not doing good in the industry: 67.35% of the companies in the same industry are doing better.
1BAYN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for 1BAYN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.95%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
1BAYN.MI Yearly Profit, Operating, Gross Margins1BAYN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

1BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
1BAYN has about the same amout of shares outstanding than it did 1 year ago.
1BAYN has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1BAYN has an improved debt to assets ratio.
1BAYN.MI Yearly Shares Outstanding1BAYN.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
1BAYN.MI Yearly Total Debt VS Total Assets1BAYN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

Based on the Altman-Z score of 0.78, we must say that 1BAYN is in the distress zone and has some risk of bankruptcy.
1BAYN has a worse Altman-Z score (0.78) than 73.47% of its industry peers.
1BAYN has a debt to FCF ratio of 8.37. This is a slightly negative value and a sign of low solvency as 1BAYN would need 8.37 years to pay back of all of its debts.
1BAYN has a Debt to FCF ratio (8.37) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.04 is on the high side and indicates that 1BAYN has dependencies on debt financing.
1BAYN's Debt to Equity ratio of 1.04 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 65.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 8.37
Altman-Z 0.78
ROIC/WACCN/A
WACC6.28%
1BAYN.MI Yearly LT Debt VS Equity VS FCF1BAYN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

1BAYN has a Current Ratio of 1.13. This is a normal value and indicates that 1BAYN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 1BAYN (1.13) is worse than 69.39% of its industry peers.
1BAYN has a Quick Ratio of 1.13. This is a bad value and indicates that 1BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
1BAYN's Quick ratio of 0.73 is on the low side compared to the rest of the industry. 1BAYN is outperformed by 73.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.73
1BAYN.MI Yearly Current Assets VS Current Liabilites1BAYN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

3

3. Growth

3.1 Past

1BAYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.36%.
The Earnings Per Share has been decreasing by -5.27% on average over the past years.
Looking at the last year, 1BAYN shows a decrease in Revenue. The Revenue has decreased by -1.99% in the last year.
The Revenue has been growing slightly by 1.37% on average over the past years.
EPS 1Y (TTM)-16.36%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%30.85%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.63%

3.2 Future

The Earnings Per Share is expected to grow by 3.05% on average over the next years.
Based on estimates for the next years, 1BAYN will show a small growth in Revenue. The Revenue will grow by 1.19% on average per year.
EPS Next Y-6.48%
EPS Next 2Y-1.54%
EPS Next 3Y2.06%
EPS Next 5Y3.05%
Revenue Next Year-1.18%
Revenue Next 2Y-0.09%
Revenue Next 3Y0.7%
Revenue Next 5Y1.19%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1BAYN.MI Yearly Revenue VS Estimates1BAYN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
1BAYN.MI Yearly EPS VS Estimates1BAYN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.45, the valuation of 1BAYN can be described as very cheap.
95.92% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.20. 1BAYN is valued rather cheaply when compared to this.
1BAYN is valuated cheaply with a Price/Forward Earnings ratio of 5.58.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1BAYN indicates a rather cheap valuation: 1BAYN is cheaper than 95.92% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of 1BAYN to the average of the S&P500 Index (22.70), we can say 1BAYN is valued rather cheaply.
Industry RankSector Rank
PE 5.45
Fwd PE 5.58
1BAYN.MI Price Earnings VS Forward Price Earnings1BAYN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1BAYN is valued a bit cheaper than the industry average as 73.47% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1BAYN indicates a rather cheap valuation: 1BAYN is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.84
EV/EBITDA 8.88
1BAYN.MI Per share data1BAYN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.54%
EPS Next 3Y2.06%

More info and screens

0

5. Dividend

5.1 Amount

With a yearly dividend of 0.38%, 1BAYN is not a good candidate for dividend investing.
1BAYN's Dividend Yield is slightly below the industry average, which is at 3.04.
Compared to an average S&P500 Dividend Yield of 2.38, 1BAYN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.38%

5.2 History

The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of 1BAYN are negative and hence is the payout ratio. 1BAYN will probably not be able to sustain this dividend level.
DP-3.69%
EPS Next 2Y-1.54%
EPS Next 3Y2.06%
1BAYN.MI Yearly Income VS Free CF VS Dividend1BAYN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

More info and screens

BAYER AG-REG

BIT:1BAYN (9/17/2025, 7:00:00 PM)

27.3

+0.15 (+0.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-06 2025-08-06/dmh
Earnings (Next)11-12 2025-11-12
Inst Owners41.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.82B
Analysts71.43
Price Target29.62 (8.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.38%
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-3.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.87%
Min EPS beat(2)1.86%
Max EPS beat(2)45.89%
EPS beat(4)3
Avg EPS beat(4)8.47%
Min EPS beat(4)-17.26%
Max EPS beat(4)45.89%
EPS beat(8)6
Avg EPS beat(8)3.46%
EPS beat(12)8
Avg EPS beat(12)1.61%
EPS beat(16)12
Avg EPS beat(16)4.59%
Revenue beat(2)0
Avg Revenue beat(2)-1.8%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-0.98%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.92%
Revenue beat(12)3
Avg Revenue beat(12)-2.37%
Revenue beat(16)7
Avg Revenue beat(16)-1.04%
PT rev (1m)2.46%
PT rev (3m)5.51%
EPS NQ rev (1m)-0.22%
EPS NQ rev (3m)19.4%
EPS NY rev (1m)2.38%
EPS NY rev (3m)2.38%
Revenue NQ rev (1m)0.23%
Revenue NQ rev (3m)-3.39%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-1.05%
Valuation
Industry RankSector Rank
PE 5.45
Fwd PE 5.58
P/S 0.58
P/FCF 5.84
P/OCF 3.75
P/B 0.88
P/tB N/A
EV/EBITDA 8.88
EPS(TTM)5.01
EY18.35%
EPS(NY)4.9
Fwd EY17.93%
FCF(TTM)4.67
FCFY17.12%
OCF(TTM)7.28
OCFY26.66%
SpS47
BVpS30.91
TBVpS-18.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.25%
ROE -11.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.95%
FCFM 9.94%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 8.37
Debt/EBITDA 4.79
Cap/Depr 32.07%
Cap/Sales 5.54%
Interest Coverage N/A
Cash Conversion 107.94%
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.73
Altman-Z 0.78
F-Score4
WACC6.28%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.36%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%30.85%
EPS Next Y-6.48%
EPS Next 2Y-1.54%
EPS Next 3Y2.06%
EPS Next 5Y3.05%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.63%
Revenue Next Year-1.18%
Revenue Next 2Y-0.09%
Revenue Next 3Y0.7%
Revenue Next 5Y1.19%
EBIT growth 1Y-161.08%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.3%
EBIT Next 3Y21.17%
EBIT Next 5Y10.79%
FCF growth 1Y1068.78%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y169.98%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%